Qi Pan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Predicting progression from amnestic mild cognitive impairment to Alzheimer's disease using longitudinal EEG data: a 12-month cohort study.
Journal: Frontiers in aging neuroscience
Published: October 07, 2025
RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia.
Journal: The EMBO journal
Published: April 14, 2025
Construction of a Rat Model of Hemilateral Parkinson's Disease Induced by Human Wild-Type α-Synuclein Overexpression.
Journal: Neuropsychiatric disease and treatment
Published: March 27, 2025
Calcium homeostasis modulator 2 aggravates α-synuclein-induced neurotoxicity in Parkinson's disease by activating PARP-1 depended Parthanatos.
Journal: Human molecular genetics
Published: December 09, 2024
METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.
Journal: EMBO reports
Published: July 10, 2022
The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1.
Journal: Cell discovery
Published: March 26, 2022
Polysome profiling followed by quantitative PCR for identifying potential micropeptide encoding long non-coding RNAs in suspension cell lines.
Journal: STAR protocols
Published: January 03, 2022
The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease.
Journal: Oxidative medicine and cellular longevity
Published: August 23, 2021
Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application.
Journal: Blood science (Baltimore, Md.)
Published: August 09, 2021
The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma.
Journal: Cancer biology & medicine
Published: August 04, 2021
Last Updated: 09/26/2026